亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Subcutaneous Delivery of High-Dose/Volume Biologics: Current Status and Prospect for Future Advancements

药物输送 医学 加药 输送系统 药理学 纳米技术 材料科学
作者
Advait Badkar,Rajesh B. Gandhi,Shawn P. Davis,Michael J. LaBarre
出处
期刊:Drug Design Development and Therapy [Dove Medical Press]
卷期号:Volume 15: 159-170 被引量:37
标识
DOI:10.2147/dddt.s287323
摘要

Abstract: Subcutaneous (SC) delivery of biologics has traditionally been limited to fluid volumes of 1– 2 mL, with recent increases to volumes of about 3 mL. This injection volume limitation poses challenges for high-dose biologics, as these formulations may also require increased solution concentration in many cases, resulting in high viscosities which can affect the stability, manufacturability, and delivery/administration of therapeutic drugs. Currently, there are technologies that can help to overcome these challenges and facilitate the delivery of larger amounts of drug through the SC route. This can be achieved either by enabling biologic molecules to be formulated or delivered as high-concentration injectables (> 100 mg/mL for antibodies) or through facilitating the delivery of larger volumes of fluid (> 3 mL). The SC Drug Delivery and Development Consortium, which was established in 2018, aims to identify and address critical gaps and issues in the SC delivery of high-dose/volume products to help expand this delivery landscape. Identified as a high priority out of the Consortium’s eight problem statements, it highlights the need to shift perceptions of the capabilities of technologies that enable the SC delivery of large-volume (> 3 mL) and/or high-dose biologics. The Consortium emphasizes a patient-focused approach towards the adoption of SC delivery of large-volume/high-concentration dosing products to facilitate the continued expansion of the capabilities of novel SC technologies. To raise awareness of the critical issues and gaps in high-dose/volume SC drug development, this review article provides a generalized overview of currently available and emerging technologies and devices that could facilitate SC delivery of high-dose/volume drug formulations. In addition, it discusses the challenges, gaps, and future outlook in high-dose/volume SC delivery as well as potential solutions to exploit the full value of the SC route of administration. Keywords: high-dose biologic, drug delivery technologies, subcutaneous drug delivery, intravenous drug delivery, patient preference, large-volume subcutaneous delivery
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
21秒前
伍美华发布了新的文献求助10
26秒前
毓香谷的春天完成签到 ,获得积分10
45秒前
51秒前
ach发布了新的文献求助10
55秒前
CodeCraft应助ach采纳,获得10
1分钟前
康KKKate完成签到 ,获得积分10
1分钟前
rocky15应助messi采纳,获得10
2分钟前
Savitr完成签到 ,获得积分10
2分钟前
Flexy发布了新的文献求助10
3分钟前
3分钟前
执着的草丛完成签到,获得积分10
3分钟前
白云朵儿发布了新的文献求助10
4分钟前
4分钟前
嘎嘎好使完成签到 ,获得积分10
4分钟前
畅畅完成签到,获得积分10
4分钟前
JC完成签到 ,获得积分10
4分钟前
还在考虑完成签到,获得积分10
5分钟前
孤独蘑菇完成签到 ,获得积分10
5分钟前
rocky15应助py999采纳,获得10
5分钟前
rocky15应助slzyycy采纳,获得10
6分钟前
乐乐应助Huang采纳,获得10
6分钟前
可爱的函函应助parpate采纳,获得10
6分钟前
慕青应助Wei采纳,获得10
6分钟前
6分钟前
Huang发布了新的文献求助10
6分钟前
7分钟前
白云朵儿发布了新的文献求助10
7分钟前
薯片呀完成签到 ,获得积分10
7分钟前
从容松弛完成签到 ,获得积分10
8分钟前
隐形曼青应助丁染采纳,获得10
9分钟前
9分钟前
py999驳回了rocky15应助
9分钟前
tcklikai发布了新的文献求助10
9分钟前
丁染完成签到,获得积分10
9分钟前
9分钟前
丁染发布了新的文献求助10
9分钟前
10分钟前
白云朵儿发布了新的文献求助10
10分钟前
10分钟前
高分求助中
Un calendrier babylonien des travaux, des signes et des mois: Séries iqqur îpuš 1036
Sustainable Land Management: Strategies to Cope with the Marginalisation of Agriculture 1000
Corrosion and Oxygen Control 600
Heterocyclic Stilbene and Bibenzyl Derivatives in Liverworts: Distribution, Structures, Total Synthesis and Biological Activity 500
重庆市新能源汽车产业大数据招商指南(两链两图两池两库两平台两清单两报告) 400
Division and square root. Digit-recurrence algorithms and implementations 400
行動データの計算論モデリング 強化学習モデルを例として 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 有机化学 工程类 生物化学 纳米技术 物理 内科学 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 电极 光电子学 量子力学
热门帖子
关注 科研通微信公众号,转发送积分 2545572
求助须知:如何正确求助?哪些是违规求助? 2175642
关于积分的说明 5600185
捐赠科研通 1896368
什么是DOI,文献DOI怎么找? 946248
版权声明 565371
科研通“疑难数据库(出版商)”最低求助积分说明 503557